No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
492 |
4. Check minimum number of eventsNone |
492 |
5. Include endpointsNone |
492 |
6. Filter based on genotype QC (FinnGen only) |
440 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of renal pelvis, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of urinary organs, including Hilmo
- Solid cancers, including Hilmo
- Malignant neoplasm, wide definition
- Malignant neoplasm, including Hilmo
- Neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 440 | 116 | 324 |
| Unadjusted period prevalence (%) | 0.12 | 0.04 | 0.15 |
| Median age at first event (years) | 71.69 | 71.57 | 71.73 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 456
- Matched controls
- 4560
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
307.7
417
*
UKC02
NOMESCO Finland
Cystoscopy
26.6
276.8
349
498
8120/3-C65.9
ICD-O-3
Transitional cell carcinoma, NOS, of renal pelvis
+∞
230.4
201
*
R31
ICD-10 Finland
Unspecified haematuria
17.4
220.0
267
343
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
163.7
147
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
43.3
160.5
99
29
H02AB02
ATC
dexamethasone; systemic
52.4
152.0
89
21
130
Kela drug reimbursment
Malignant tumour
+∞
151.8
137
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
33.5
146.8
98
37
UKB02
NOMESCO Finland
Retrograde ureteroscopy
65.4
145.2
81
15
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
930.1
143.2
133
*
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
+∞
138.8
126
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
33.4
131.0
87
32
JN4AD
NOMESCO Finland
Body CT examination
13.6
130.9
144
150
KAC20
NOMESCO Finland
Nephroureterectomy
+∞
129.5
118
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
120.3
110
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
202.7
119.9
120
8
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
58.1
114.2
65
13
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
1115.5
95.5
90
*
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
287.1
93.3
92
*
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
46.0
88.6
53
13
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
14.3
88.5
87
74
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
267.9
87.8
87
*
Z51.5
ICD-10 Finland
Palliative care
10.7
86.9
107
127
C66
ICD-10 Finland
Malignant neoplasm of ureter
+∞
84.0
78
*
A03FA01
ATC
metoclopramide; systemic, rectal
7.6
80.6
142
257
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
193.4
78.9
80
5
B01AB10
ATC
tinzaparin; parenteral
8.4
78.4
121
189
A04AA01
ATC
ondansetron; systemic, rectal
21.7
76.6
59
31
JN4CD
NOMESCO Finland
Very extensive body CT
23.4
72.7
54
26
C61
ICD-10 Finland
Malignant neoplasm of prostate
780.6
70.0
67
*
JN4BD
NOMESCO Finland
Extensive body CT
10.3
69.4
85
99
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
66.3
62
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
57.5
54
*
TPH07
NOMESCO Finland
Cathetrisation of artery
5.6
54.4
128
298
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
108.3
53.2
57
6
A04AA02
ATC
granisetron; systemic, transdermal
+∞
53.2
50
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
53.2
50
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
18.2
52.0
43
26
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
6.7
51.0
92
166
KH1AD
NOMESCO Finland
CT of urinary organs
9.6
50.1
63
75
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
49.9
47
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
519.6
48.3
47
*
XX3DW
NOMESCO Finland
Time consuming IT work
8.8
48.0
65
85
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.1
45.5
116
286
U06
ICPC
Haematuria
10.9
45.3
51
52
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
9.6
43.5
54
63
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
43.4
41
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
42.4
40
*
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
16.0
42.1
37
25
KA1AE
NOMESCO Finland
Kidney ultrasound examination
11.2
38.3
42
41
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
38.1
36
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.7
38.0
105
274
N02AA05
ATC
oxycodone; systemic
3.9
37.0
140
461
116
Kela drug reimbursment
Prostate cancer
+∞
37.0
35
*
B01AB05
ATC
enoxaparin; parenteral
3.4
35.7
202
861
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
33.3
157
593
WX402
NOMESCO Finland
General anaesthesia
3.9
32.8
123
399
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
32.7
31
*
8130/2-C65.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of renal pelvis
+∞
31.6
30
*
B02AA02
ATC
tranexamic acid; systemic
4.9
30.7
76
180
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
+∞
30.6
29
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
30.6
29
*
ZX136
NOMESCO Finland
Intravesicalis
165.9
30.0
31
*
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
+∞
29.5
28
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.2
29.1
161
663
WW500
NOMESCO Finland
Blood transfusion
9.6
29.0
35
39
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
27.4
26
*
WZC30
NOMESCO Finland
Teaching
3.8
27.2
97
301
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
39.4
26.5
33
9
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
26.3
25
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
25.2
24
*
L03AA02
ATC
filgrastim; parenteral
+∞
25.2
24
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.6
25.0
97
318
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
263.9
24.9
25
*
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
45.7
24.9
30
7
WF002
NOMESCO Finland
Radical radiotherapy
137.5
24.9
26
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
91.8
23.9
26
*
KC1GB
NOMESCO Finland
Cystography with X-ray
91.8
23.9
26
*
L02AE02
ATC
leuprorelin; implant, parenteral
131.9
23.8
25
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
23.1
22
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
23.1
22
*
KAD52
NOMESCO Finland
Retrograde ureteronephroscopic destruction of tumour of pelvis of kidney
+∞
23.1
22
*
J01MA02
ATC
ciprofloxacin; systemic
2.6
23.0
235
1306
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.3
22.7
40
69
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
7.7
22.3
32
44
TKC20
NOMESCO Finland
Catheterisation of bladder
3.9
22.3
74
217
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
22.1
21
*
KCC10
NOMESCO Finland
Cystoprostatectomy
+∞
22.1
21
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.7
21.9
77
235
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
230.6
21.8
22
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
8.3
21.5
29
37
XKD00
NOMESCO Finland
Uroflowmetry
2.9
21.2
128
541
GD1AD
NOMESCO Finland
Thorax CT examination
4.6
21.1
54
130
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
63.1
21.1
24
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
21.0
20
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
21.0
20
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
21.0
20
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
20.5
272
1682
KCW96
NOMESCO Finland
Other operations on bladder
60.4
20.1
23
*
KAB00
NOMESCO Finland
Biopsy of kidney or pelvis of kidney
+∞
19.9
19
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
19.9
19
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.9
19.9
113
461
KC1GD
NOMESCO Finland
CT cystography of bladder
208.7
19.7
20
*
J01EA01
ATC
trimethoprim; systemic
2.7
19.4
133
598
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
23.8
19.3
27
12
KBV10
NOMESCO Finland
Removal of stent from ureter
36.1
19.1
24
7
A04AD12
ATC
aprepitant; systemic
+∞
18.9
18
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
18.9
18
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
8.0
18.9
26
34
7126
FHL
Nephroureterectomy
+∞
17.8
17
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
17.8
17
*
8000/3-C65.9
ICD-O-3
Neoplasm, malignant of renal pelvis
+∞
17.8
17
*
KA3GB
NOMESCO Finland
Retrograde pyelography
187.0
17.6
18
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
187.0
17.6
18
*
N02AX02
ATC
tramadol; systemic, rectal
2.3
16.8
230
1401
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
16.8
16
*
KBB00
NOMESCO Finland
Biopsy of ureter
+∞
16.8
16
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
5.1
16.7
36
75
J01MA12
ATC
levofloxacin; systemic
2.6
16.0
120
559
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.8
15.8
89
358
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
+∞
15.7
15
*
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
88.2
15.7
17
*
1530
FHL
Urethrocystoscopy
5.9
15.3
28
50
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
21.9
14.8
21
10
U75
ICPC
Malignant neoplasm of kidney
+∞
14.7
14
*
1891C
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Renal pelvis[NEOPLASMA MALIGNUM PELVIS RENIS,MUU/TARK MÄÄR SYÖPÄ]
+∞
14.7
14
*
115
Kela drug reimbursment
Breast cancer
+∞
14.7
14
*
KA3EB
NOMESCO Finland
Antegrade pyelography
82.8
14.7
16
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
14.5
126
625
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.9
14.4
44
121
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.3
14.1
58
194
ZX120
NOMESCO Finland
Intravenous
3.5
13.7
49
150
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.5
13.7
99
450
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
13.6
13
*
197
Kela drug reimbursment
Sunitinib
+∞
13.6
13
*
1891X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Renal pelvis[NEOPLASMA MALIGNUM PELVIS RENIS,EI HIST VAHV]
+∞
13.6
13
*
U76
ICPC
Malignant neoplasm of bladder
+∞
13.6
13
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
13.6
13
*
8120/3-C68.9
ICD-O-3
Transitional cell carcinoma, NOS, of urinary system, NOS
+∞
13.6
13
*
WX725
NOMESCO Finland
Noninvasive ventilation
3.9
13.5
41
112
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.5
13.3
47
143
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
12.9
171
1002
L03AA13
ATC
pegfilgrastim; parenteral
71.9
12.7
14
*
KH1DD
NOMESCO Finland
CT urography of urinary organs
71.9
12.7
14
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
12.6
12
*
L02BB03
ATC
bicalutamide; oral
+∞
12.6
12
*
C67
ICD-10 Finland
Malignant neoplasm of bladder
+∞
12.6
12
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.8
12.5
29
64
N18.8
ICD-10 Finland
Other chronic renal failure
4.8
12.5
29
64
L02BG04
ATC
letrozole; oral
133.5
12.5
13
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.6
12.3
77
325
B03XA02
ATC
darbepoetin alfa; parenteral
9.3
11.9
24
27
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
66.7
11.7
13
*
N30.0
ICD-10 Finland
Acute cystitis
2.6
11.5
76
329
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
+∞
11.5
11
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
11.5
11
*
8120/3-C66.9
ICD-O-3
Transitional cell carcinoma, NOS, of ureter
+∞
11.5
11
*
KBD00
NOMESCO Finland
Partial excision of ureter
+∞
11.5
11
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
11.5
11
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
11.5
11
*
A79
ICPC
Malignancy NOS
123.0
11.5
12
*
Y77
ICPC
Malignant neoplasm prostate
123.0
11.5
12
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
36.0
11.3
14
*
ZXC20
NOMESCO Finland
Use of chemical agents
10.4
11.1
21
21
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.7
10.6
63
258
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
10.5
10
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
10.5
10
*
1888X
ICD-9 Finland
Malignant neoplasm of bladder, Other specified sites of bladder
+∞
10.5
10
*
C68.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of urinary organs
+∞
10.5
10
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
10.5
10
*
KBC00
NOMESCO Finland
Ureterectomy
+∞
10.5
10
*
Z3231
NOMESCO Finland
Registered nurse
2.1
10.4
128
719
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.6
10.4
25
57
KBV00
NOMESCO Finland
Insertion of stent into ureter
24.0
10.3
14
6
ZXE00
NOMESCO Finland
One hour or less
1.9
10.2
173
1089
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
10.4
10.1
19
19
A02BC02
ATC
pantoprazole; systemic
1.9
9.9
304
2313
KDE20
NOMESCO Finland
Removal of foreign body from urethra
20.6
9.9
14
7
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
9.9
9.9
19
20
7321
FHL
TU biopsy, coagulation or laser
56.2
9.7
11
*
N02BE01
ATC
paracetamol; systemic, rectal
2.4
9.6
395
3323
R50.9
ICD-10 Finland
Fever, unspecified
2.3
9.5
76
358
J01DB01
ATC
cefalexin; oral
2.0
9.5
349
2803
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
102.1
9.4
10
*
7125
FHL
Nephrectomy (extrrafascial)
102.1
9.4
10
*
KCD30
NOMESCO Finland
Destruction of tumour of bladder
+∞
9.4
9
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
9.4
9
*
8120/3-C68.8
ICD-O-3
Transitional cell carcinoma, NOS, of overlapping lesion of urinary organs
+∞
9.4
9
*
L01XE04
ATC
[U] sunitinib
+∞
9.4
9
*
C68.0
ICD-10 Finland
Malignant neoplasm: Urethra
+∞
9.4
9
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
9.4
9
*
WX320
NOMESCO Finland
Spinalanesthesy
2.0
9.2
127
742
ZXA05
NOMESCO Finland
Left side
2.0
9.1
129
758
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.7
9.1
29
82
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.9
8.9
26
69
WX892
NOMESCO Finland
Monitored bed care
2.6
8.7
51
207
ZXC15
NOMESCO Finland
Use of photodynamic technique
11.9
8.6
15
13
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
91.7
8.4
9
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
91.7
8.4
9
*
7323
FHL
Electrosection of TU bladder wall change
91.7
8.4
9
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
91.7
8.4
9
*
KBH20
NOMESCO Finland
Replantation of ureter
91.7
8.4
9
*
R4110
NOMESCO Finland
Physiotherapy
1.9
8.4
123
729
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.7
8.4
27
77
1502
Kela drug reimbursment
Cabozantinib
+∞
8.4
8
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
8.4
8
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
8.4
8
*
3012
Kela drug reimbursment
Cabozantinib
+∞
8.4
8
*
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
+∞
8.4
8
*
KBD22
NOMESCO Finland
Retrograde ureteroscopic destruction of tumour of ureter
+∞
8.4
8
*
322
Kela drug reimbursment
Sunitinib
+∞
8.4
8
*
UJF32
NOMESCO Finland
Coloscopy
1.9
8.3
123
731
J01CA08
ATC
pivmecillinam; oral
1.9
8.3
126
756
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
8.2
168
1109
C03CA01
ATC
furosemide; systemic
1.8
8.2
208
1463
XX2RW, ,
NOMESCO Finland
17.6
8.1
12
7
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
34.0
8.1
10
*
KCB00
NOMESCO Finland
Biopsy of bladder
34.0
8.1
10
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.3
8.1
30
94
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
8.0
50
210
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
4.1
8.0
22
56
JEA00
NOMESCO Finland
Appendectomy
3.7
7.8
25
71
A06AH03
ATC
naloxegol; oral
15.4
7.8
12
8
H02AB06
ATC
prednisolone; systemic
1.7
7.7
212
1517
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
18.7
7.6
11
6
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
18.7
7.6
11
6
JFB30
NOMESCO Finland
Right hemicolectomy
25.5
7.6
10
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
81.4
7.4
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
81.4
7.4
8
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
7.3
7
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
7.3
7
*
8130/2-C66.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of ureter
+∞
7.3
7
*
KAC00
NOMESCO Finland
Nephrectomy
+∞
7.3
7
*
UKC12
NOMESCO Finland
Retrograde endoscopy of cutaneous cystoenterostomy
+∞
7.3
7
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
7.3
7
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
7.3
7
*
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
+∞
7.3
7
*
KB1CG
NOMESCO Finland
Extensive MRI examination of urinary tract with high intensity magnet
+∞
7.3
7
*
UKB12
NOMESCO Finland
Retrograde endoscopy of cutaneous ureteroenterostomy
+∞
7.3
7
*
WX224
NOMESCO Finland
Blockade of obturius nerve
+∞
7.3
7
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
7.3
7
*
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
+∞
7.3
7
*
R33
ICD-10 Finland
Retention of urine
2.2
7.3
69
348
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
7.2
7.1
16
23
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.0
7.0
85
471
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
11.2
6.8
12
11
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.4
6.8
17
40
N20.9
ICD-10 Finland
Urinary calculus, unspecified
4.0
6.8
19
49
ZXC96
NOMESCO Finland
Robot assisted procedure
40.7
6.8
8
*
UKD02
NOMESCO Finland
Urethroscopy
17.0
6.8
10
6
NK6AN
NOMESCO Finland
Total body bone isotope imaging
22.9
6.7
9
*
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
10.2
6.6
12
12
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
7.0
6.6
15
22
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.6
6.5
37
148
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.6
6.5
21
60
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.5
6.5
22
65
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
70.8
6.4
7
*
J01MA14
ATC
moxifloxacin; systemic
2.3
6.4
48
219
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
6.4
82
462
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
6.3
6
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
6.3
6
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
6.3
6
*
159
Kela drug reimbursment
Pazopanib
+∞
6.3
6
*
1890B
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,ADENOCARCINOMA]
+∞
6.3
6
*
C64.80
ICD-10 Finland
Wilms tumour
+∞
6.3
6
*
8120/2-C65.9
ICD-O-3
Urothelial carcinoma in situ of renal pelvis
+∞
6.3
6
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
6.3
6
*
L01EX01
ATC
sunitinib; oral
+∞
6.3
6
*
C67.6
ICD-10 Finland
Malignant neoplasm: Ureteric orifice
+∞
6.3
6
*
L01EX07
ATC
cabozantinib; oral
+∞
6.3
6
*
L02BX02
ATC
degarelix; parenteral
+∞
6.3
6
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
6.3
6
*
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
27.1
6.2
8
*
TJF80
NOMESCO Finland
Ostomy education
27.1
6.2
8
*
A06AD11
ATC
lactulose; oral
1.9
6.2
91
535
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.4
6.2
22
67
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
6.4
6.2
15
24
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
6.2
264
2079
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
6.1
196
1438
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
208
874
3.54
38.09
6.3
2.4
3.46
4.04
e6/l
0.66
188
787
257
1243
3.45
37.28
9.9
3.2
179.78
121.12
e6/l
0.32
222
941
286
1492
3.46
36.33
3.9
2.5
—
—
estimate
—
0
0
156
563
3.69
35.86
10.6
6.1
105.22
104.43
mmol/l
1.10
156
563
229
1066
3.31
34.76
9.9
3.0
0.32
0.40
e6/l
0.54
197
768
81
196
4.81
31.90
3.7
1.3
36.23
2.83
ug/l
0.69
68
150
260
1361
3.12
31.29
10.7
3.8
228.57
109.16
e6/l
0.58
226
967
113
359
3.86
30.93
9.5
5.8
11.81
11.31
mmol/l
0.25
105
341
359
2312
3.60
29.32
12.1
4.8
81.00
2007.37
e6/l
—
5
46
147
582
3.25
28.29
5.3
2.4
0.83
0.83
mmol/l
0.10
142
539
177
793
3.01
27.34
3.1
2.2
—
—
—
0
0
279
1600
2.92
27.07
8.5
3.9
32.76
35.01
g/l
6.90
262
1471
109
373
3.53
26.37
5.4
2.0
233.73
239.76
u/l
0.33
104
347
130
508
3.18
25.25
9.7
6.5
13.16
11.28
kpa
4.20
121
491
130
508
3.18
25.25
9.7
6.5
5.20
5.07
kpa
0.94
121
490
305
1899
2.83
24.18
12.3
6.0
1.19
1.21
mmol/l
1.68
268
1617
281
1695
2.71
23.43
11.9
5.6
1.20
1.20
mmol/l
0.73
269
1529
126
508
3.05
22.95
9.8
6.5
-0.97
1.09
mmol/l
6.16
101
413
148
658
2.85
22.50
9.2
2.9
1.73
1.08
e6/l
0.80
109
344
79
245
3.69
21.95
12.6
8.3
23.13
24.29
mmol/l
2.30
74
239
288
1799
2.63
21.70
15.0
5.4
4.68
4.47
e9/l
0.53
247
1538
301
1946
2.61
20.69
20.1
20.1
1.28
1.38
inr
2.44
252
1651
326
2214
2.66
19.82
8.6
4.7
6.85
6.89
mmol/l
0.14
314
2110
135
615
2.70
19.18
9.8
3.0
0.98
2.10
e6/l
1.87
97
299
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
51
131
4.26
18.32
3.6
2.4
0.39
0.42
iu/ml
0.18
29
73
35
71
5.26
16.69
4.6
1.9
79.00
15.68
u/ml
0.47
29
53
355
2613
2.62
16.58
14.3
5.5
93.42
78.70
u/l
4.14
348
2407
80
300
3.02
16.14
1.7
2.1
0.21
0.19
g/l
0.75
74
267
76
293
2.91
14.53
5.5
3.9
122.52
99.33
ng/l
0.98
66
249
25
21
12.52
14.25
1.2
1.7
42.00
25.48
ng/l
0.93
25
21
197
1184
2.17
14.21
7.4
2.0
2.34
2.35
mmol/l
0.24
181
1017
118
578
2.41
13.88
3.6
2.5
19.57
22.60
%
1.79
113
535
131
672
2.33
13.87
3.4
2.5
10.15
12.36
umol/l
3.31
124
617
123
624
2.33
13.30
3.4
2.4
2.09
2.20
g/l
1.26
115
572
267
1870
2.03
12.14
6.9
4.0
0.00
0.02
estimate
0.80
71
368
97
464
2.39
11.87
6.5
3.2
5.79
5.80
kpa
0.03
90
451
185
1152
2.02
11.57
4.1
2.3
477.85
62.09
u/l
0.50
178
1065
259
1827
1.97
11.17
6.6
4.0
0.00
0.00
estimate
-0.00
70
379
262
1858
1.96
11.09
6.8
4.0
0.00
0.00
estimate
-0.00
72
391
90
453
2.23
9.65
6.9
3.1
1.14
2.02
mmol/l
1.09
71
389
165
1048
1.90
9.30
2.3
2.3
2.95
2.91
mg/l
0.09
145
879
15
12
12.88
8.92
1.9
2.4
7.21
4.33
nmol/l
0.43
15
12
128
769
1.92
8.41
5.4
2.1
2.50
2.45
mmol/l
5.22
113
665
58
265
2.36
7.74
3.5
2.3
48.51
57.30
ml/min/173m2
1.41
37
106
121
742
1.86
7.35
2.2
1.8
—
—
—
0
0
130
827
1.80
6.97
5.7
4.5
88.34
370.01
ng/l
2.72
119
723
144
955
1.74
6.64
3.6
2.6
401.98
369.03
umol/l
2.85
128
798
156
1063
1.71
6.51
7.9
4.0
0.00
0.00
estimate
-0.00
54
342
54
260
2.22
6.38
1.6
1.6
—
—
—
0
0
34
132
2.70
6.37
3.4
1.3
72.25
33.72
mg/l
1.21
29
111
34
133
2.68
6.28
3.4
1.3
51.37
46.35
mg/l
0.32
29
111
202
1484
1.65
6.27
3.7
2.9
224.40
155.10
ug/l
2.34
183
1344
52
250
2.22
6.16
6.5
3.7
1.83
2.17
mmol/l
0.19
39
180
31
117
2.77
6.12
3.3
1.3
1.27
1.42
ratio
0.39
18
71
12
14
8.77
6.09
1.8
1.1
—
—
—
0
0
96
579
1.83
6.05
2.2
1.8
—
—
—
0
0
42
190
2.33
5.74
2.6
1.7
1.79
1.60
g/l
0.55
34
164
39
172
2.39
5.64
1.6
1.5
2.26
2.73
ug/l
0.12
32
144
377
3302
1.82
5.52
34.2
16.5
39.21
27.62
mg/l
7.45
363
2718
88
537
1.79
5.30
2.3
1.9
—
—
—
0
0
5
0
+∞
5.22
4.0
0.0
42.68
—
u/ml
—
5
0
59
320
1.97
5.10
3.1
1.6
66.63
66.50
g/l
0.04
50
284
23
82
2.90
5.05
1.2
1.2
—
—
—
0
0
68
393
1.86
4.87
4.5
2.8
4.99
4.46
kpa
0.55
62
378
23
87
2.73
4.56
1.1
1.3
—
—
—
0
0
23
89
2.67
4.37
1.1
1.3
—
—
—
0
0
29
128
2.35
4.22
1.1
1.3
81.29
117.50
u/ml
—
7
49
10
17
5.99
4.15
3.6
3.1
0.50
1.06
index
—
10
17
237
1927
1.48
4.10
5.2
4.4
2.51
2.10
ug/l
0.64
192
1714
19
69
2.83
4.07
1.2
1.1
—
—
—
0
0
31
145
2.22
3.96
4.1
3.3
—
—
—
0
0
179
1388
1.48
3.87
7.5
4.0
0.04
0.01
estimate
0.38
51
307
42
225
1.95
3.79
1.7
1.5
—
—
—
0
0
19
72
2.71
3.78
1.3
1.2
—
—
—
0
0
17
61
2.86
3.73
1.2
1.2
—
—
—
0
0
299
2572
1.47
3.71
4.4
4.2
20.26
13.07
mm/h
6.54
276
2348
23
99
2.39
3.56
5.9
3.6
2.27
1.21
index
0.82
15
54
22
93
2.43
3.54
1.3
1.6
—
—
—
0
0
6
6
10.11
3.50
1.0
1.2
352.33
83.17
nmol/l
—
6
6
185
1470
1.43
3.42
3.3
3.4
3408.44
1761.45
ng/l
1.97
171
1276
63
396
1.69
3.40
5.4
3.3
—
—
—
0
0
128
954
1.48
3.30
5.9
3.6
6.71
0.00
estimate
0.62
45
296
61
386
1.67
3.21
4.0
3.7
391.00
246.66
ng/l
0.93
54
361
8
18
4.50
2.80
1.0
1.4
—
—
—
0
0
8
18
4.50
2.80
1.0
1.4
—
—
—
0
0
13
48
2.76
2.74
1.2
2.3
282.92
285.53
mu/l
0.01
13
43
11
35
3.19
2.66
6.6
1.5
1012.91
1134.09
mg
0.07
11
35
98
722
1.46
2.64
1.7
1.7
2.25
1.46
mg/l
1.25
86
564
378
3493
1.48
2.56
45.7
21.2
138.86
139.76
mmol/l
7.73
373
3409
374
3453
1.46
2.51
18.9
10.6
23.64
25.83
u/l
2.08
364
3302
378
3498
1.47
2.49
46.5
21.3
4.13
4.03
mmol/l
8.37
373
3411
44
275
1.66
2.45
2.3
1.6
—
—
—
0
0
345
3148
1.39
2.40
38.3
16.2
56.91
72.63
ml/min/173m2
31.44
334
2929
8
22
3.68
2.37
1.1
1.1
—
—
—
0
0
6
13
4.66
2.28
1.0
1.0
—
—
—
0
0
6
13
4.66
2.28
1.0
1.2
—
—
—
0
0
6
13
4.66
2.28
1.0
1.2
—
—
—
0
0
6
13
4.66
2.28
1.0
1.2
—
—
—
0
0
6
13
4.66
2.28
1.0
1.2
—
—
—
0
0
27
151
1.84
2.21
2.1
1.6
—
—
—
0
0
159
1308
1.33
2.18
2.0
2.2
130.45
311.95
u/l
2.28
150
1227
293
2629
1.32
2.13
45.3
19.9
14.39
13.76
%
11.18
288
2586
25
140
1.83
2.05
2.1
1.5
—
—
—
0
0
276
2471
1.30
1.96
5.0
3.8
15.09
15.13
pmol/l
0.10
244
2195
6
16
3.78
1.94
1.2
1.1
—
—
—
0
0
173
1461
1.30
1.92
4.1
4.3
21.97
8.92
mg/mmol
2.07
117
944
171
1442
1.30
1.92
3.5
3.5
6.68
7.65
mmol/l
3.13
140
1205
379
3555
1.39
1.90
52.6
24.7
246.13
232.73
e9/l
2.94
372
3451
16
79
2.06
1.87
1.3
1.3
—
462.50
—
0
8
133
1090
1.31
1.83
3.3
3.0
0.92
0.79
ug/l
0.46
88
739
5
12
4.20
1.83
1.0
1.5
—
—
—
0
0
5
12
4.20
1.83
1.0
1.5
—
—
—
0
0
378
3555
1.37
1.76
52.7
24.7
4.18
4.46
e12/l
19.07
368
3435
12
54
2.26
1.75
1.1
1.4
—
—
—
0
0
9
36
2.53
1.75
2.2
1.9
—
284.40
—
0
5
7
24
2.95
1.73
1.1
1.1
—
—
—
0
0
8
31
2.61
1.66
1.1
1.3
—
—
—
0
0
10
41
2.47
1.65
1.1
1.4
—
—
—
0
0
181
1565
1.26
1.61
4.4
4.1
23.39
24.42
%
0.40
96
783
22
130
1.73
1.56
1.2
1.3
—
—
—
0
0
16
86
1.89
1.52
1.7
1.4
—
—
—
0
0
13
65
2.03
1.50
3.2
1.4
—
—
—
0
0
105
857
1.29
1.48
8.3
4.3
1.02
1.02
kg/l
0.13
89
562
7
28
2.52
1.45
1.1
1.1
—
—
—
0
0
7
28
2.52
1.45
1.1
1.1
—
—
—
0
0
7
28
2.52
1.45
1.1
1.1
—
—
—
0
0
10
198
0.49
1.42
2.9
2.2
3.56
3.55
ratio
—
10
169
9
40
2.27
1.41
1.3
1.2
—
—
—
0
0
227
2037
1.23
1.38
3.5
3.2
69.82
53.63
u/l
1.08
215
1876
6
23
2.63
1.37
1.2
1.5
92.43
78.40
ng/l
—
6
23
5
17
2.96
1.36
2.6
3.5
—
—
—
0
0
11
55
2.02
1.28
1.1
1.4
—
0.14
nmol/l
—
0
5
121
1414
0.80
1.26
1.9
1.9
1.46
1.27
mmol/l
1.83
105
1141
16
92
1.77
1.26
1.2
1.4
—
—
—
0
0
188
1668
1.22
1.25
5.2
4.4
52.30
63.81
ng/l
0.21
163
1327
205
1836
1.21
1.24
2.3
2.3
90.44
94.48
pmol/l
0.69
120
964
7
141
0.49
1.23
2.7
1.9
2.81
3.45
mmol/l
—
7
115
10
49
2.06
1.23
2.0
1.4
—
—
—
0
0
98
813
1.26
1.21
1.8
1.8
1021.39
1158.50
nmol/l
0.66
77
609
6
26
2.32
1.19
1.2
1.2
—
—
—
0
0
0
35
0.00
1.15
0.0
1.1
—
1.31
—
0
18
5
20
2.52
1.15
1.2
1.2
—
—
—
0
0
7
30
2.35
1.12
1.0
1.3
—
—
—
0
0
27
185
1.49
1.11
2.7
2.2
370.11
674.74
ug/l
0.50
27
174
5
21
2.40
1.09
1.2
1.1
—
—
—
0
0
7
32
2.21
1.08
1.0
1.3
—
—
—
0
0
145
1272
1.21
1.06
1.8
1.8
16.88
19.98
nmol/l
1.87
125
1053
11
60
1.85
1.03
4.3
3.3
10.20
11.25
pmol/l
0.15
11
60
14
83
1.71
1.02
2.1
1.7
—
—
—
0
0
9
48
1.89
1.01
1.0
1.3
—
—
—
0
0
106
906
1.22
1.01
1.6
1.8
396.54
5510061.56
pmol/l
0.50
82
726
0
29
0.00
0.98
0.0
1.2
—
163.94
—
0
29
170
1523
1.19
0.98
2.3
2.4
76.78
78.08
nmol/l
0.23
150
1311
9
51
1.78
0.95
2.8
2.3
9.78
10.94
mmol/l
—
9
51
175
1577
1.18
0.93
2.6
2.3
—
—
—
0
0
50
624
0.78
0.92
1.2
1.3
0.55
1.60
u/ml
2.04
13
164
6
28
2.16
0.92
1.8
1.3
—
—
—
0
0
6
32
1.89
0.82
1.0
1.4
—
—
—
0
0
6
32
1.89
0.82
1.2
2.5
—
—
—
0
0
6
34
1.77
0.76
1.2
1.3
—
—
—
0
0
9
54
1.68
0.75
3.4
4.1
—
—
—
0
0
14
92
1.54
0.73
1.3
1.2
—
—
—
0
0
43
522
0.81
0.65
1.2
1.3
96.57
38.97
iu/ml
0.44
13
157
319
3061
1.14
0.62
6.3
4.8
2.04
2.01
mu/l
0.11
289
2741
6
35
1.72
0.58
1.2
1.3
—
—
—
0
0
6
35
1.72
0.58
1.2
1.3
—
—
—
0
0
40
481
0.82
0.57
1.2
1.3
13.81
11.17
u/ml
0.08
17
157
6
36
1.68
0.57
1.2
1.3
—
—
—
0
0
6
36
1.68
0.57
1.2
1.3
—
—
—
0
0
6
36
1.68
0.57
1.2
1.3
—
—
—
0
0
35
285
1.25
0.56
1.4
1.5
—
—
—
0
0
15
108
1.40
0.53
1.3
1.3
—
—
—
0
0
9
133
0.67
0.52
1.4
1.9
49.11
44.56
nmol/l
—
9
124
6
40
1.51
0.51
1.2
1.1
—
—
—
0
0
7
109
0.64
0.49
1.7
2.0
180.29
215.03
pmol/l
—
7
102
35
295
1.20
0.43
1.0
1.3
—
—
—
0
0
5
31
1.62
0.43
1.2
2.5
—
—
—
0
0
5
32
1.57
0.42
1.0
1.0
—
—
—
0
0
0
18
0.00
0.40
0.0
1.4
—
15.19
—
0
13
7
104
0.67
0.40
1.6
1.5
55861.14
14946.36
e6/l
—
7
77
50
439
1.16
0.39
2.8
2.8
3.29
7.70
ug/l
4.77
45
381
5
80
0.62
0.35
1.2
1.2
—
3.00
—
0
11
25
297
0.83
0.35
1.6
1.9
1.56
1.72
%
0.68
20
247
52
465
1.13
0.33
12.3
8.4
—
—
—
0
0
6
46
1.31
0.33
1.0
1.3
235.67
272.72
pmol/l
—
6
39
11
84
1.32
0.30
1.5
1.3
—
—
—
0
0
11
84
1.32
0.30
1.5
1.3
—
—
—
0
0
9
118
0.76
0.27
1.0
1.3
—
—
—
0
0
5
72
0.69
0.26
1.2
1.2
—
1.16
—
0
5
302
3088
0.93
0.26
4.4
4.7
1.37
1.27
mmol/l
1.02
267
2770
6
82
0.73
0.24
1.0
1.2
633.50
513.25
mg/l
—
6
77
6
83
0.72
0.24
1.2
1.2
—
—
—
0
0
13
106
1.23
0.23
1.2
1.7
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
10.73
—
0
11
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
37.28
—
0
13
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
335
3296
1.06
0.20
6.1
5.7
6.13
6.17
mmol/l
0.23
297
2950
0
14
0.00
0.20
0.0
1.1
—
1.07
—
0
7
20
176
1.14
0.17
1.4
1.3
—
—
—
0
0
6
80
0.75
0.15
1.0
1.6
—
—
—
0
0
7
90
0.77
0.14
1.0
1.2
—
—
—
0
0
7
90
0.77
0.14
1.0
1.2
—
—
—
0
0
10
117
0.85
0.13
1.0
1.0
—
—
—
0
0
11
95
1.16
0.11
1.2
1.6
—
—
—
0
0
46
483
0.95
0.10
4.7
5.3
32.18
32.85
%
0.13
28
305
5
63
0.79
0.08
1.2
1.3
—
—
—
0
0
320
3224
0.98
0.07
5.0
5.5
1.30
1.40
mmol/l
3.53
288
2919
325
3232
1.02
0.04
8.0
7.6
40.51
40.83
mmol/mol
0.32
295
2978
323
3247
0.98
0.04
5.1
5.7
4.12
4.31
mmol/l
3.01
291
2969
334
3326
1.02
0.03
5.8
6.5
2.27
2.47
mmol/l
4.55
294
3024
0
8
0.00
0.00
0.0
7.4
—
10.74
—
0
8
0
8
0.00
0.00
0.0
1.3
—
9.78
—
0
8
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
5
57
0.88
-0.00
1.2
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
0.20
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
63
0.95
-0.00
1.0
1.1
—
2.00
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
54
0.93
-0.00
1.6
5.3
12.24
7.30
mmol/l
—
5
46
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_RENAL_PELVIS_WIDE – Malignant neoplasm of renal pelvis, including Hilmo
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).